Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript


Image source: The Motley Fool.

Karyopharm Therapeutics (NASDAQ: KPTI)
Q2 2024 Earnings Call
Aug 06, 2024, 8:00 a.m. ET

Operator

Continue reading


Source Fool.com

Karyopharm Therapeutics Inc. Stock

€0.74
-0.240%
The price for the Karyopharm Therapeutics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.002 (-0.240%).
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 0.74 € the target price of 5 € shows a potential of 574.04% for Karyopharm Therapeutics Inc. which would more than double the current price.
Like: 0
Share

Comments